Combined vaccine for infants to protect against six diseases
Part of Immune system & allergy clinical trials.
This trial tests a new combined vaccine that protects against six diseases (diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio) in Indonesian infants. It aims to see if it is safe and produces a good immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 6 and 11 weeks old.
- Your baby was born full-term (between 37 and 42 weeks of pregnancy).
- Your baby weighed more than 2.5 kg (about 5.5 pounds) at birth.
- You or another legal guardian can give informed consent and follow the study schedule.
- Your baby is not currently enrolled in another trial and has no serious illness, fever, or allergy to vaccine components.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combined vaccine that protects against several serious diseases in one shot. It aims to check if the vaccine is safe and works well in infants and toddlers.
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
This trial tests a new combination vaccine that protects infants against diphtheria, tetanus, and whooping cough. It is for healthy 3-month-old babies whose parents have not yet given them a similar shot.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
Hear when a new Vaccine Adverse Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.